Page last updated: 2024-12-05

biphenylacetylene

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

biphenylacetylene : An arylacetylene that is acetylene in which the hydrogens are replaced by phenyl groups. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID10390
CHEMBL ID223309
CHEBI ID51579
MeSH IDM0130480

Synonyms (55)

Synonym
AC-18803
nsc 5185
y70ja8hb75 ,
ai3-04360
unii-y70ja8hb75
einecs 207-926-6
CHEBI:51579 ,
biphenylacetylene
acetylene, diphenyl-
diphenylacetylene ,
501-65-5
1,2-diphenylacetylene
benzene,1'-(1,2-ethynediyl)bis-
nsc-5185
nsc5185
ethyne, diphenyl-
tolane
diphenylethyne
tolan
1,1'-ethyne-1,2-diyldibenzene
inchi=1/c14h10/c1-3-7-13(8-4-1)11-12-14-9-5-2-6-10-14/h1-10
benzene, 1,1'-(1,2-ethynediyl)bis-
diphenylacetylene, 98%
D0871
CHEMBL223309
2-phenylethynylbenzene
AKOS004901131
1,2-diphenyl ethyne
(phenylethynyl)benzene
FT-0625223
(2-phenylethynyl)benzene
(phenylethynyl)benzene;1,1'-(1,2-ethanediyl)bisbenzene;1,1?-(1,2-ethynediyl)bis-benzen;1,1?-(1,2-ethynediyl)bisbenzene;1,2-diphenylacetylene
1,2-diphenylethyne
biphenyl acetylene
diphenyl acetylene
DTXSID4060109
(phenylethynyl)benzene #
J-650163
tolan [mi]
1,1-(1,2-ethynediyl)bisbenzene
FD10621
STL453635
J-520382
mfcd00004786
bdbm50476289
1-(2-phenyl-1-ethynyl)benzene
Q902100
diphenylacetylene-d 10
diphenyl-acetylene
AS-56973
YSWG033
SY012762
EN300-19945
25989-14-4
CS-W017313
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
fluorochromeA fluorescent dye used to stain biological specimens.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
arylacetyleneAn acetylene with the general formula R(1)-C#C-R(2) where at least one of R(1) or R(2) is an aryl group.
benzenesAny benzenoid aromatic compound consisting of the benzene skeleton and its substituted derivatives.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID286796Displacement of [125I]IMPY from human beta amyloid plaque in brain homogenates2007Journal of medicinal chemistry, May-17, Volume: 50, Issue:10
New diphenylacetylenes as probes for positron emission tomographic imaging of amyloid plaques.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (46)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (2.17)18.7374
1990's0 (0.00)18.2507
2000's13 (28.26)29.6817
2010's25 (54.35)24.3611
2020's7 (15.22)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 10.72

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index10.72 (24.57)
Research Supply Index3.85 (2.92)
Research Growth Index4.57 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (10.72)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other46 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]